Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
19.49
+0.35 (1.83%)
Jun 3, 2025, 3:04 PM CST

Chongqing Zhifei Biological Products Company Description

Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China.

The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysaccharide Conjugate Vaccine under the Mening A Con brand; and other developed products.

It also provides cold storage services. Chongqing Zhifei Biological Products Co., Ltd. was founded in 2002 and is based in Chongqing, China.

Chongqing Zhifei Biological Products Co., Ltd.
Country China
Founded 2002
Industry Biotechnology
Sector Healthcare
Employees 7,220
CEO Lingfeng Jiang

Contact Details

Address:
Building T1
Chongqing, 400020
China
Phone 86 23 8635 8685
Website zhifeishengwu.com

Stock Details

Ticker Symbol 300122
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000V20
SIC Code 2836

Key Executives

Name Position
Lingfeng Jiang Vice Chairman of the Board and President
Zhen Jing Li CPA Vice President, Chief Financial Officer and Director
Zhijun Wang Chief Engineer
Fei Qin Vice President, Secretary of Board and Director
Yu Zhang Vice president
Zhang Jing Vice President
Jie Shao Vice President
Hong Fan Vice President